We are live on
!
Find out more
Parallel Advisors Portfolio holdings
AUM
$6.56B
Turnover
11.49%
1-Year Est. Return
32.24%
This Fund
S&P 500
This Quarter
Est. Return
+7.1%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$2.69B
AUM Growth
+$214M
(+8.6%)
Cap. Flow
+$72.4M
Cap. Flow
% of AUM
2.69%
Top 10 Holdings %
Top 10 Hldgs %
36.8%
Holding
3,484
New
256
Increased
1,490
Reduced
872
Closed
231
Avg Time Held Equity + Options
2.8
years
Top 10 Avg Time Held Equity + Options
2.2
years
Top 20 Avg Time Held Equity + Options
2.1
years
Avg Time Held Equity only
2.8
years
Top 10 Avg Time Held Equity only
2.2
years
Top 20 Avg Time Held Equity only
2.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$29.6M |
| 2 |
iShares Core S&P Small-Cap ETF
IJR
|
+$14.8M |
| 3 |
iShares TIPS Bond ETF
TIP
|
+$14.3M |
| 4 |
Payoneer
PAYO
|
+$13.7M |
| 5 |
Doximity
DOCS
|
+$13M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Treasury Bond ETF
GOVT
|
+$17.7M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$15.8M |
| 3 |
FTOC
FTAC Olympus Acquisition Corp. Class A Ordinary Shares
FTOC
|
+$15.5M |
| 4 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$10.4M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$8.96M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 51.24% |
| 2 | Technology | 16.87% |
| 3 | Financials | 7.26% |
| 4 | Healthcare | 6.41% |
| 5 | Consumer Discretionary | 5.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3076
Bicycle Therapeutics
BCYC
$252M
| $0 | ﹤0.01% |
+5
| New | +$276 |
2021 Q4
0 quarters
|
|
3077
Belden
BDC
$4.07B
| $0 | ﹤0.01% |
+5
| New | +$314 |
2021 Q4
0 quarters
|
|
3078
Black Diamond Therapeutics
BDTX
$100M
| – | – |
-298
| Closed | -$3K | – |
|
3079
Beam Global
BEEM
$21.7M
| – | – |
-5
| Closed | – | – |
|
3080
KE Holdings
BEKE
$19.6B
| $0 | ﹤0.01% |
+19
| New | +$389 |
2021 Q4
0 quarters
|
|
3081
Braemar Hotels & Resorts
BHR
$95.5M
| $0 | ﹤0.01% |
88
| – | – |
2021 Q2
2 quarters
|
|
3082
Ballard Power Systems
BLDP
$586M
| – | – |
-5
| Closed | – | – |
|
3083
Bionano Genomics
BNGO
$16.1M
| – | – |
-1
| Closed | -$2K | – |
|
3084
Bolt Biotherapeutics
BOLT
$8.17M
| – | – |
-4
| Closed | -$1K | – |
|
3085
Bentley Systems
BSY
$10.9B
| $0 | ﹤0.01% |
4
+3
| +300% | +$162 |
2021 Q3
1 quarter
|
|
3086
AGF US Market Neutral Anti-Beta Fund
BTAL
$326M
| $0 | ﹤0.01% |
23
| – | – |
2020 Q1
7 quarters
|
|
3087
Bit Digital
BTBT
$389M
| $0 | ﹤0.01% |
1
| – | – |
2021 Q3
1 quarter
|
|
3088
BrightView Holdings
BV
$975M
| – | – |
-113
| Closed | -$2K | – |
|
3089
Bioventus
BVS
$943M
| $0 | ﹤0.01% |
21
-312
| -94% | -$4.43K |
2021 Q3
1 quarter
|
|
3090
BeyondSpring
BYSI
$23.9M
| – | – |
-160
| Closed | -$3K | – |
|
3091
DELISTED
Carisma Therapeutics
CARM
| – | – |
-38
| Closed | -$1K | – |
|
3092
Cato Corp
CATO
$47M
| $0 | ﹤0.01% |
+16
| New | +$275 |
2021 Q4
0 quarters
|
|
3093
CCC Intelligent Solutions
CCC
$4.49B
| – | – |
-1,836
| Closed | -$19K | – |
|
3094
C4 Therapeutics
CCCC
$342M
| – | – |
-106
| Closed | -$5K | – |
|
3095
Cadiz
CDZI
$323M
| $0 | ﹤0.01% |
60
-136
| -69% | -$735 |
2020 Q1
7 quarters
|
|
3096
Cenntro
CENN
$7.74M
| – | – |
0
| – | – |
2021 Q2
2 quarters
|
|
3097
Cognyte Software
CGNT
$651M
| – | – |
-49
| Closed | -$1K | – |
|
3098
Coherus Oncology
CHRS
$162M
| $0 | ﹤0.01% |
+6
| New | +$105 |
2021 Q4
0 quarters
|
|
3099
Cipher Digital
CIFR
$4.17B
| $0 | ﹤0.01% |
20
| – | – |
2021 Q3
1 quarter
|
|
3100
Chimera Investment
CIM
$716M
| $0 | ﹤0.01% |
9
| – | – |
2016 Q4
20 quarters
|
|
Similar funds
Parallel Advisors's Q4 2021 Portfolio in Review
As of Q4 2021, Parallel Advisors held 3,484 positions worth $2.69B, up 8.6% from $2.48B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Parallel Advisors's Q4 2021 filing shows 256 new, 1,490 increased, 872 reduced and 231 closed positions. Its largest new stake was Payoneer: 1,784,455 shares worth $13.1M. The largest sale was iShares US Treasury Bond ETF, an estimated $17.7M.
By sector, the portfolio is most concentrated in Miscellaneous at 51% of assets, down from 52% a quarter earlier, followed by Technology and Financials.
- Parallel Advisors's largest Q4 2021 buy was Payoneer: 1,784,455 shares worth $13.1M.
- Parallel Advisors added most to iShares Core MSCI EAFE ETF in Q4 2021, an estimated $29.6M increase.
- Parallel Advisors's biggest Q4 2021 reduction was iShares US Treasury Bond ETF, cutting an estimated $17.7M.
- Parallel Advisors fully exited FTAC Olympus Acquisition Corp. Class A Ordinary Shares in Q4 2021, selling an estimated $15.5M.
- Parallel Advisors's ten largest holdings make up 37% of its $2.69B portfolio in Q4 2021.
- Parallel Advisors opened 256 new positions and closed 231 in Q4 2021.
- Parallel Advisors's portfolio value rose 8.6% quarter-over-quarter to $2.69B.
Based on Parallel Advisors's 13F filing for Q4 2021, filed 20 Jan 2022.